Microsoft word - study guide 5th year 2014.docx

FACULTY OF PHARMACY
SEMESTER 9 & 10
ISSUED BY: REGISTRARS OFFICE.
CONTENTS
1.1 Why we need Study guide 1.2 The Curriculum 1.3 Learning Methods
2. ZCP STUDENT CODE OF CONDUCT …………………………………………………3 - 9
The Conduct of students Disciplinary offence Disciplinary actions Disciplinary procedure Structure of the disciplinary and appeal committees Disciplinary authority
3. WHO TO CONTACT …………………………………………………………………….10

4. Pharm.D CURRICULUM, FOP………………………………………….……………….11

5. SCHEME OF COURSES FOR Pharm. D. (5th YEAR SEMESTER SYSTEM)……….….12

6. COURSE OBJECTIVES ………………………………………………….…………….13 - 32

7. BOOKS OF Pharm. D 5th Year ………………………………………………………33 - 35
8. EXAMINATION RULES AND REGULATION, FOP ………………………………….36 - 42
General rules and regulation
8. 1 Courses 8. 2 Types of examination 8. 3 Marking system / Pass level 8. 4 Grading system 8. 5 Eligibility for regular semester examination 8. 6 Eligibility for Resit examination 8. 7 Promotion rules 8. 8 Rules for Repeating the year 8. 9 Declaration of result 8. 10 Issuance of Marks Sheet 8. 11 Requirement for the award of Pharm.D degree 8. 12 Unfair means 8. 13 External Examiner 9. TEST ADMINISTRATION RULES AND REGULATION, FOP …………………………43 - 46
9. 1 General 9. 2 Irregular behavior 9. 3 Advice for students 9. 4 Evaluation of students (1) INTRODUCTION
1.1. WHY WE NEED STUDY GUIDE?
• To inform students how the learning programme has been organized year wise and how it wil be implemented. • To help students to organize or to manage their studies throughout the The Guide provides:
• Information on organization and management of the year. This will help you to contact the right individual in case you have any difficulty. • A description of the course objectives which you wil be expected to achieve at the end of each course. • Information on learning methods that you will experience during the course. The methods include Tutorials, Lectures, Skil s/Practicals, Presentations and Visit to Pharmaceutical Industries. These learning methods should help you to achieve the course objectives. • A description of the learning resources available for the year. These may include books, videos and others. • Information regarding rules and regulations of semester examination. • Information on the methods of assessments that wil be held to determine your achievement of objectives. 1.2. THE CURRICULUM:
Curriculum Organization:
Two semesters of the same duration (16 to 17 weeks) shal be offered in
one academic year.
Weekly Schedule:
This is posted on the notice board weekly. You MUST read the notice
board to find out the schedule and/or announcement. Al courses and
continuous assessment of the semester wil be held according to the
schedule.
Course Number:
Each course is identified by a number.

Course Objective:
All courses have defined objectives in terms of what students are
expected to achieve on completion of each course. Your academic
experiences including learning methods and assessment have been
designed relevant to the objectives.

1.3. LEARNING METHODS:
The fol owing learning methods/strategies are used to promote better understanding: ♦ Tutorials
♦ Presentations / Seminars
♦ Lectures
♦ Seminars
♦ Practicals
♦ Field visits
♦ Assignments
(Hospitals / Pharmaceutical
Industries)

In addition to the above programme emphasis is given on:

• Self Directed Study: Students may achieve objectives by assuming
responsibilities of their own learning HOW? By sharing and discussing
with peers, working individual y, seeking information from LRC, inter
and intranet, teachers and resource persons within the Faculty. This is
possibly achieved by utilizing scheduled self-study periods in the
Faculty.
(2) ZIAUDDIN UNIVERSITY (ZU) STUDENTS CODE OF

2.1. INTRODUCTION:
2.1.1. The ZU was established with the objective of developing human resources
appropriately equipped to deal with the problems which are of particular relevance to its environment. The University considers its students to be mature and responsible individuals and makes al efforts for developing and matching professional attributes.
2.1.2. The University expects that behavior of the students within and outside the
premises of the University wil be in conformity with the highest standards of honesty, morality and discipline. The students will respect the rights and privileges of the members of the university community at all times. They wil refrain from conduct that might damage the reputation of the University or any of its programmes.
2.1.3. The students wil refrain from any conduct that may lead to the disruption
of an academic programme of the University and from cheating and plagiarism in any set up of the University.
2.2. THE CONDUCT OF STUDENTS:
2.2.1. General Conduct:

All students shal present themselves with dignity befitting their status as mature, professional and responsible citizens. a. Students in al settings on campus are expected to dress in a simple and decent manner. b. Students individual y or as a group, wil obtain written ZU approval before organizing or assisting in organizing demonstrations, rallies or picketing on campus. c. Students individual y or as a group wil refrain from disseminating or cause to disseminate material or engage in activity which hinder or prevent the ful participation of another person or group in the life of the University. d. Religious and social activities held on campus must have prior written University authorization. e. Students wil ensure that their actions do not endanger or threaten the health, safety or wel being of other persons. f. Students wil refrain from such any behavior, which can be interpreted by others as sexual harassment. g. Students wil obtain written authorization before making any public statements, communication, or correspondence with the press or other media for mass communication on behalf of the University. h. Unless otherwise authorized in writing the students wil refrain from representatives of foreign governments/agencies or other public personalities in their official capacity on campus. i. Students wil refrain from any activity, which is subversive of discipline and may constitute misconduct. 2.2.2. ACADEMIC CONDUCT:

All students wil diligently apply themselves to their registered courses of study. They wil maintain confidentiality of information and wil use it in no other circumstances than for professional and authorized academic purposes. a. Students are required to attend lectures, tutorials, seminars, Practicals, industrial tours / visits, clerkships, examinations and other scheduled courses and activities assignments given by the except for such reasons acceptable to the University. b. Students wil ensure that any original academic writing, including essays, theses, research projects or assignments in a course or programme of study either represents their own words, ideas, images or data is appropriately referenced. c. Students wil obtain authorization, before procuring, possessing, distributing or receiving any confidential material pertaining to academic tests, examinations and research or laboratory results from any source. d. Students wil respect the confidentiality of information pertaining to patients, including their records or files.
2.3 RULES:

• Students of ZU are required to exhibit good attitude and discipline. Guidelines have been delineated in the University's Code of Conduct ("Code of Conduct") framed by the University to provide students with a reference to the standards for discipline. It is expected that al students wil strictly uphold and adhere to the Code of Conduct, but in cases where there are grounds to suspect a breach or any infringement of the Code of Conduct or disregard or contempt of the Code of Conduct, disciplinary action may be initiated for such behavior committed either within or outside the premises of the University or any establishment, project or setting thereof anywhere located. The reference to the expression "University" shal mean and include (unless the context provides otherwise), any establishment, project or setting of the University located anywhere in the world. • The disciplinary procedure shal be fol owed on any breach and/or infringement of the Code of Conduct as defined hereunder. Along with the offences which are liable to disciplinary action and the decision making authority.
2.4 DISCIPLINARY OFFENCE:
Without prejudice to the generality of the provisions of the Code of Conduct and the provisions of Rules 3.3.1 and 3.3.2 the fol owing conduct wil constitute disciplinary offence. 2.4.1 MINOR OFFENCES:
• Repeated failure to abide to scheduled instruction, practical work, examination, clinical assignments and or incite other students to act likewise. • Smoking, eating, drinking in prohibited areas in settings of the
NOTE: All minor offenses wil be dealt with as major if repeated.

2.4.2 MAJOR OFFENCES:
• Assault on students, members of staff, or patients. • Any form of unauthorized picketing, ral ies, demonstrations or organized obstructions of any student/ University staff/ University Hospital function in any manner whatsoever. • Any attempt to conceive, design or affect any plan of whatever nature whose object or consequence is to disrupt academic programme of the University or its operations. • Malicious acts, theft, wil ful damage or misuse of University property. • Disorderly conduct and/or molestation and disrespect of other members of the University community within and outside the University premises. • Bringing unauthorized persons in the university premises or any other academic settings. • Cheating, plagiarism and / or use of unfair means in examinations or any other academic settings. • Possession, use and display of firearms, drugs, alcohol or other contraband items in campus or at University related events. • Any other offence which is considered contrary to the academic

2.5 DISCIPLINARY ACTIONS:
The University shal have the powers to impose any one or more of the fol owing actions. However, nothing wil preclude the University from requiring any student or parent or both to execute any indemnity bond, assurance or undertaking to support expected conduct throughout his/her stay at the University.
MINOR DISCIPLINARY OFFENCE wil be liable to one or more of the
fol owing sanctions:
• Counseling of the student. • Probation: A student can be placed on probation for a specific period of time with mandatory periodic Counseling. • A letter of warning or reprimand to the student with information to the • The payment of fine by the offender commensurate with the nature and gravity of the offence committed amounting up to 5% of the annual fees of the student.
MAJOR DISCIPLINARY OFFENCE wil be liable to one or more of the
fol owing sanctions:
a. Suspension from the University for a Specific Period. b. Expulsion from the University. c. Any other penalty, which the University may deem, fit to impose. 2.6 DISCIPLINARY PROCEDURE:

The fol owing steps wil be fol owed for disciplinary procedure.
2.6.1 Any disciplinary offence not of serious nature may be brought to the
attention of the offender by an affected student through the /staff member concerned of the University. The purpose of this in the first instance is to resolve the matter through constructive criticism, counseling and/or admonition. The expression "offence not of serious nature" appearing herein above shall be such offence as is considered as an offence of not a serious nature by the /staff member of the University in his/her sole discretion. The expression "/staff member of the University" shal , in relation to the fol owing Units of the University namely: (i) Medical Faculty, (ii) The School of Nursing, (ii) School of Physical Therapy (iv) Institute of Medical Technology (v) Faculty of Pharmacy, mean the members of the staff/ nominated by the head of each of the said Units as the member of the staff/ to deal with matters related to students' complaints or any offence by students. 2.6.2 If the matter is not resolved or the student repeats an offence or if the
offence is a serious one, the head of the Unit concerned of the University i.e. (i) in case of the Medical Faculty/Faculty of Pharmacy – the Dean, (i ) in case of Institute of Medical Technology – respective Directors and (i i) in case of School of Physiotherapy, School of Nursing, respective Principals or their nominees wil be informed, who shal advise investigation by the Disciplinary Committee constituted under Rule 3.7.1. The outcome of the investigation shal be communicated to the head of the relevant Unit. He/She may act upon the recommendation of the Disciplinary Committee or in accordance with his/her judgment. The decision shal then be communicated or in accordance with his/her judgment. The decision shal then be communicated to the offender. The matter shal be resolved normal y within fourteen working days from the day of Head of the Unit is informed of the offence.
2.6.3 A student may appeal in writing against such a decision to the Head of his
Unit within ten working days of the decision having been communicated in writing to the student. The student shal within the said period of time submit his/her appeal to the Head of his Unit i.e. Dean or his designate in case of the Medical Faculty, Faculty of Pharmacy or in case of Institute of Medical and Technology – respective Director and (i i) in the case of School of Physiotherapy, School of Nursing respective Principals as the case may be for onward submission to the Vice Chancellor. The Head of the Unit shal request the Vice Chancel or to constitute an Appeal Committee under Rule 3.7.2 and refer the matter to it for consideration of the Appeal.
2.6.4 The Appeal Committee shal take up and review the case and
communicate its decision in writing to the VC normal y within ten working days. The VC may act upon the recommendations of the Appeal Committee or in accordance with his/her own judgment.
2.6.5 If the decision is not acceptable to the student, he/she may request a final
review by the VC. The VC's decision thereafter shal be final and binding.
2.7 STRUCTURE OF THE DISCIPLINARY AND APPEAL COMMITTEES

2.7.1 The structure of Disciplinary committee shal consist of five members of the,
one of whom shal be the Chairperson, Dean in case of the Faculty of Pharmacy. The Dean / Chairperson and members may serve for three years. They may be appointed for another term of two years. The Committee shal be appointed by the ZU Academic Council.
2.7.2 A University Appel ate Committee shal be appointed as and when
required, by the VC. It shal consist of three members (one of whom shal be the chairperson, Dean in case of Faculty of Pharmacy) who have not been associated with counseling or with investigation of the student's current or his/her any previous offence.
2.7.3 The Disciplinary Committee and the Appel ate Board wil have authority to
cal for evidence or questioning any person witness to the offence/event reported for investigation to the disciplinary committee.
2.8 DISCIPLINARY AUTHORITY:

Not withstanding anything contained herein, the VC shal be the final disciplinary authority of the University with powers to: a. Appoint or change a Disciplinary Committee, and define disciplinary b. Suspend the privileges of enrol ment of a student who is suspected of a breach of the code, pending investigation. c. Act upon the recommendations of the Disciplinary Committee which may include expulsion of a student from the University. d. Appoint an Appeal Committee and define procedures for appeal. e. Take any measure that may be necessary for ensuring effective disciplinary procedures. f. Delegate any of his authority. g. Make, alter and modify the Disciplinary Procedure / Rules.

2.9 DEFINITIONS:

2.9.1 STUDENT:
The said expression shal mean and include any person enrol ed with the University for a Course of studies leading to an undergraduate or postgraduate degree or diploma or certificate within the University or the University Hospital or any person registered with any other University or Institution who has been accepted for an approved programme of study or training at ZU. 2.9.2 VICE CHANCELLOR:

The VC shal be deemed to mean the VC of the University unless otherwise stated. 2.9.3 DEAN:

Unless otherwise indicated, the "Dean" shal be interpreted as the Dean of: (a) Ziauddin Medical (b) Post Graduate Studies i) Clinical ii) Basic Medical Sciences Depending on the case pertaining to any of the Units of the University. 2.9.4 UNIT:
Unless indicated otherwise, a unit shal mean the Medical, School of
Physiotherapy, The Pharmacy or any Institute, Faculty or School of the University.
2.9.5 HEAD OF THE UNIT:

Shal mean Director of the Medical Technology or Principal School of Nursing, School of Physiotherapy and Dean or his/her designate for the Medical, for the Pharmacy.
2.9.6 SUSPENSION:

Suspension requires a student to withdraw completely from al the academic activities of the University for a specified period of time. Upon expiry of the period of suspension the student wil be re-admitted, contingent upon the terms and conditions of the suspension without any obligation or liability whatsoever on the part of the University or any of its staff/ members or officers. 2.9.7 EXPULSION:
Expulsion means termination of enrol ment in the University.
2.9.8 FINE:
This is an order to student for payment of a sum of money to the University as penalty for any offence committed by the student. The student may or may not be permitted to continue with the course of studies until the fine has been paid. (3) WHO TO CONTACT

Any queries or difficulties with the schedule, learning strategy should be directed
to:
CONTACT:-
DEAN:
Dr. Ali Akbar Sial:

For further details and clarification on academic policy, programme, rules &
regulations, student attendance and progress.

CONTROLLER OF EXAMINATIONS:
Dr. Owais Ismail:
Contact only to seek further clarification on rules and regulations, policy or
progress in university professional examinations.
REGISTRAR:
Mr. Muhammad Yousaf:

University policy issues including accreditation, affiliation and fees.
STUDENTS ADVISOR:
Ms. Huma Ali / Ms. Saba Ajaz Baloch
PROCTOR:
Ms. Sarah Haroon IF you have questions about the Programme?
Read the Study Guide If your questions still remain unanswered Contact the Dean, Faculty of Pharmacy (4) PHARM.D CURRICULUM, (FOP)

The curriculum has been developed by Pharmacy Council of Pakistan (PCP) and
Higher Education Commission (HEC). It is designed to produce pharmacists who
have the abilities and skil s which are necessary to achieve outcomes related to:
• Providing pharmaceutical care to patients • Developing and managing medication distribution and control systems • Managing the Pharmacy • Promoting public health • Providing drug information and education • Providing technical aid to pharmaceutical Industry and solving problems pertinent to manufacturing of medicines In order to provide students with the opportunity to develop a strong foundation to build their skil s, the curriculum emphasizes eight major areas of instruction: • Clinical Pharmacy • Community Pharmacy • Hospital Pharmacy • Pharmaceutical Technology • Industrial Pharmacy • Pharmaceutical Chemistry • Pharmacology • Pharmacognosy • Pharmaceutical Quality Management 4.1 OBJECTIVES OF THE CURRICULUM:
The curriculum wil provide the student with an enhanced core of professional knowledge and skil s through enrichment of the biomedical, pharmaceutical, and clinical sciences, as wel as through practice experience. The curriculum wil prepare students to be practitioners who are mature in the clinical pharmacy practices.
4.2 PHARM.D OBJECTIVES:
Students should work with patients, participate in patient care rounds and attend clinical case conferences in various patients' settings to develop a ful understanding of the therapeutic management of patients. Students should acquire experiences in the clinical pharmacy practice in the fol owing settings: general medicine, inpatient/acute care area; and ambulatory health care setting (e.g., family practice centers, health maintenance organizations, and clinics); and medical specialty area (e.g., pediatrics, geriatrics, mental health, cardiology, nephrology, and nutritional support). (5) SCHEME OF COURSES FOR PHARM.D
(FIFTH YEAR)
Semester – IX
Pharmaceutics – VII A (Pharmaceutical Technology) [Th.] Pharmaceutics – VII A (Pharmaceutical Technology) [Lab.] Pharmacy Practice – VI A (Advanced Clinical Pharmacy – II) [Th.] Pharmacy Practice – VI A (Advanced Clinical Pharmacy – II) [Lab.] Pharmacy Practice – VII A (Forensic Pharmacy) [Th.] Pharmacy Practice – VII A (Pharmaceutical Management & Marketing) [Th.] Pharmaceutical Chemistry – IV A (Medicinal Chemistry) [Th.] Pharmaceutical Chemistry – IV A (Medicinal Chemistry) [Lab.] Total Cr. Hr.
Semester – X
Pharmaceutics – VII B (Pharmaceutical Technology) [Th.] Pharmaceutics – VII B (Pharmaceutical Technology) [Lab.] Pharmacy Practice – VI B (Advanced Clinical Pharmacy – II) [Th.] Pharmacy Practice – VI B (Advanced Clinical Pharmacy – II) [Lab.] Pharmacy Practice – VII B (Forensic Pharmacy) [Th.] Pharmacy Practice – VII B (Pharmaceutical Management & Marketing) [Th.] Pharmaceutical Chemistry – IV B (Medicinal Chemistry) [Th.] Pharmaceutical Chemistry – IV B (Medicinal Chemistry) [Lab.] Total Cr. Hr.
(6) COURSE OBJECTIVES
SEMESTER – IX
COURSE NO. PHARM 714
COURSE TITLE: PHARMACEUTICAL CHEMISTRY – IV A (MEDICINAL
CHEMISTRY) [THEORY]
At the end of the course, the students should be able to: ! Introduction to medicinal chemistry
• Discuss chemical constitution and biological activity (Receptor,
Theory, structure activity relationship (SAR) and Drug metabolism). • Discuss
Modern concept of rational drug design, Prodrug, Combinatorial Chemistry and computer aided drug design (CADD) and concept of antisense molecules. ! Drug Target and Drug Designing:
• Introduction and types of drug target
• Introduction to molecular modeling and computational chemistry
• Structure based designing
• Various techniques in drug synthesis
! General properties, chemistry, biological action, structure activity
relationship and the therapeutic application of the fol owing:
• Hormones: Steroidal Hormones (Testosterone, Progesterone, Estrogen,
Aldosteron and Cortisol), Proteinous Hormones (Insulin, Glucagon, Oxytocin and Vassopressin). • Anti-neoplastic agents: Tamoxifen, fluorouracil, Mercaptopurine,
Methotrexate and Vincristine. • Sedative and Hypnotics: Benzodiazepines, Barbiturates, Paraldehyde,
Glutethimide, Chloral hydrate, and alcohols. • Anaesthetics: Local anaesthetics (Procaine, Lignocaine, Eucaine,
Cocaine and Benzocaine), General anaesthetics (Cyclopropane, Halothane, Nitrous oxide, Chloroform, Thiopental Sodium, Ketamine, Methohexital, Thioamylal Sodium, Fantanyl Citrate, Tribromo Ethanol). • Analgesics and Antipyretics: Paracetamol, Salicylic analogues,
Quinolines derivatives, Pyrazolone and Pyrazolodiones, N- arylanthranilic acids, Aryl and heteroaryl acetic acid derivatives. SEMESTER – IX
COURSE NO. PHARM 722
COURSE TITLE: PHARMACEUTICAL CHEMISTRY – IV A (MEDICINAL
CHEMISTRY) [LAB]

At the end of the course, the students should be able to:
! Estimate functional groups
• Carboxylic group • Hydroxy group • Amino and nitro groups ! Determine molecular weight of organic compounds
! Perform the synthesis of the fol owing
• Synthesis of paracetamol
• Synthesis of salicylic acid.
• Synthesis of methyl salicylate
• Synthesis of Azobenzene
• Synthesis of Benzoic Acid
• Synthesis of 5-hydroxy-1, 3 – benzoxazol – 2 – one
• Synthesis of Aspirin
• Synthesis of p – nitrosophenol
• Synthesis of 3 – nitrophthalic acid
• Synthesis of o – Chlorobenzoic acid.
! Assay of the fol owing drugs:
• Sulpha drugs • Benzyl penicil in SEMESTER – X
COURSE NO. PHARM 719
COURSE TITLE: PHARMACEUTICAL CHEMISTRY – IV B (MEDICINAL
CHEMISTRY) [THEORY]
At the end of the course, the students should be able to: ! General properties, chemistry, biological action, structure activity
relationship and the therapeutic application of the fol owing:
• Sulfonamide
- Prontosil, Sulphanilamide, Sulphapyridine, Sulphadimidine, Sulphamethoxazole, Sulfadiazine and sulfafurazole. • Antimalarials
- 4 – Aminoquinolins, 8 Aminoquinolines, 9-Amino acridines, Biguanuides, Pyrimidine analogus, Mefloquine and Cinchona • Diuretics
- Mercaptomerin, Meral uride, Thiazides, Sprironolactone, Theophyl ine, Furosemide, Acetazolamide, Ethacrynic Acid and • Anti tubercular Drugs
- Ethambutol, Isonicotinic acid, Hydrazide, Rifampacin, Thioguanine, Pyrazinamide, Cycloserine, Ethunamide, Cytarabine, 5-Flourouracil and Dacarbazine. • Antiviral Drugs
- Acyclovir, Tromantadine Hydrochloride and Ribavirin • Immunosuppressant Agent
- Azathioprine and Cyclosporin • Antibiotics
- Penicil ins, Cephalosporins, Streptomycin, Chloramphenicol, Tetracyclines, Kanamycin and Erythromycin. SEMESTER – X
COURSE NO: PHARM 725
COURSE TITLE: PHARMACEUTICAL CHEMISTRY – IV B (MEDICINAL
CHEMISTRY) [LAB]

At the end of the course, the students should be able to:
! Estimate functional groups
• Carboxylic group • Hydroxy group • Amino and nitro groups ! Determine molecular weight of organic compounds
! Perform the synthesis of the fol owing
• Synthesis of paracetamol
• Synthesis of salicylic acid.
• Synthesis of methyl salicylate
• Synthesis of Azobenzene
• Synthesis of Benzoic Acid
• Synthesis of 5-hydroxy-1, 3 – benzoxazol – 2 – one
• Synthesis of Aspirin
• Synthesis of p – nitrosophenol
• Synthesis of 3 – nitrophthalic acid
• Synthesis of o – Chlorobenzoic acid.
! Assay of the fol owing drugs:
• Sulpha drugs • Benzyl penicil in ! Discuss synthesis of inorganic preparation and derivitization
SEMESTER – IX
COURSE NO. PHARM 710
COURSE TITLE: PHARMACY PRACTICE – VII A (PHARMACEUTICAL
TECHNOLOGY) [THEORY]
At the end of the course, the students should be able to: ! Define principles of pharmaceutical formulation and dosage form design
and be able to:
• Describe product formulation
• Describe need for dosage form.
• Explain initial physiochemical characterization.
• Describe pka determinations.
• Describe initial solubility.
• Describe initial stability investigations.
• Describe crystal inity.
• Describe crystal morphology.
• Describe hygroscopicity.
• Describe salt selection.
! Define formulation development and be able to:
• Discuss aerosols.
• Describe particle sizing.
• Describe formulation of aerosols.
• Describe candidate drug selection for ophthalmic preparations.
• Describe product design considerations for ophthalmic preparations.
• Describe packaging design considerations.
• Describe ophthalmic suspensions.
• Describe ophthalmic solutions eye-drops.
• Describe viscous ophthalmic solutions.
• Describe semi – solid gel suspensions.
• Describe guiding principles for simple parenterals solutions.
• Describe pH and Tonicity requirements for parenterals.
• Describe choice of excipients for parenterals.
• Describe sterility considerations.
• Describe strategies for formulating poorly soluble drugs.
• Explain strategies for formulating unstable molecules.
• Describe manufacturing of parenteral products.
• Describe packaging of parenteral products.
! Define advanced formulation techniques and be able to:
• Describe concept of preformulation and activities.
• Explain experimental design.
• Describe development of a formulation methodology and flow plan
for the new product. • Describe new technologies in drug delivery systems.
! Define novel drug delivery systems and be able to:
• Describe liposomes, Niosomes and biodegradable polymers.
• Explain active and passive drug delivery system.
• Describe other novel GIT systems.
! Advanced Granulation technology (Design and Practice), Spray drying,
Granulation technology, Rol er compaction technology, Extrusion/
Spheronization as a Granulation technique, Single pot processing.
• Granulation Technology : Rapid Release Granulation Technique, Particle coating by centrifugation granulation technology, Polymers used in Drug Delivery systems ! Novel drug delivery systems(DDS)
• Sustained /Control ed Release drug delivery systems' • Microencapsulation technique • Coacervation. • Solvent evaporation. • Interfacial polymerization • Spray drying ! Developmental aspects of matrix& reservoir systems
SEMESTER – IX
COURSE NO. PHARM 720
COURSE TITLE: PHARMACY PRACTICE – VII A (PHARMACEUTICAL
TECHNOLOGY) [LAB]
At the end of the course, the students should be able to: ! Perform various techniques to develop the formulation.
! Perform experiments related to granulation technology, e.g. solids and
! Evaluate various systems for drug delivery.
! Evaluate biotechnological aspect of product development.
! Perform in – vitro equality control of various dosage forms.
! Particle size analysis using various methods.
! Stability studies of Pharmaceuticals, Preparation and coating of particles.
SEMESTER – X
COURSE NO. PHARM 715
COURSE TITLE: PHARMACY PRACTICE – VII B (PHARMACEUTICAL
TECHNOLOGY) [THEORY]
At the end of the semester the students should be able to: ! Define modified drug release dosage form and be able to:
• Describe modified release dosage form
• Discuss concept of sustained release
• Discuss first order release approximation
• Discuss multiple dosage designing and various approaches to
• Discuss approaches based upon dosage form modification
• Discuss product evaluation and testing
• Define matrices table
• Describe control release technology
• Discuss micro encapsulation method of particle coating
• Discuss instruments in granule manufacturing e.g. wet, dry, fluid bed
! Define Pharmaceutical Biotechnology and be able to:
• Describe Pharmaceutical biotechnology
• Discuss biotechnological aspect in the product development
• Discuss fundamentals of genetic engineering
• Discuss application of genetic engineering in medicine
• Define monoclonal antibodies
• Discuss principle, synthesis and application of monoclonal antibodies
• Define gene therapy
• Describe significance and application of gene therapy
• Define Immobilized enzyme
• Discuss application of immobilized enzyme system in medicine
• Describe microbial assay
• Discuss various methods for microbial assays
! Novel GIT Drug Delivery Systems
• Oral osmotic Pumps. • Ion – Exchange Control ed DDS. • Ph- Control ed DDS. • Bio/mucoadhesive DDS • Floating DDS. ! Drug carrier systems
! Targeted Drug Delivery systems
• Active drug delivery systems • Passive drug delivery systems ! Biotechnology
• Genetics/ Genomics, Proteomics, Biomolecular target, identification, Pharmacogenomics, Nucleic acid therapeutics. • Techniques in Biotechnology, PCR, DNA sequencing, Affinity protein Purification. Pharmaceutical Recombinant therapeutic proteins, Growth factors, Therapeutic antibodies, High throughput screening of putative therapeutic compounds. SEMESTER – X
COURSE NO. PHARM 723
COURSE TITLE: PHARMACY PRACTICE – VII B (PHARMACEUTICAL
TECHNOLOGY) (LAB.)
At the end of the course, the students should be able to: ! Perform microbial assay by various techniques
! Perform particle size analysis using various techniques
! Examine specification of packaging material
! Perform coating of particles
! Evaluate stability parameters of Pharmaceutical
! Perform Quality control test on packaging material
SEMESTER – IX
COURSE NO. PHARM 711
COURSE TITLE: PHARMACY PRACTICE – VI A (ADVANCED CLINICAL
PHARMACY – II) [THEORY]
At the end of the course, the students should be able to: ! Discuss general introduction to rationale use of drugs and be able to:
Discuss rationale for prescribing drugs.
Describe problems of irrational drug use.
Describe problems in drug sampling.
Describe various indications of drug use.
! Discuss introduction to essential drugs and be able to:
Explain various drug selection criteria for different debilitating
diseases, like cancer, AIDS and certain genetic disease such as, sickle cel anemia. Describe usage of essential drugs for prevention and cure of
debilitating diseases. Describe advantages and disadvantages of essential drugs, such as
atenolol, simvastatin, digoxin, corticosteroids. ! Discuss drug utilization evaluation and drug utilization review (DUE/DUR)
and be able to:
Describe the purpose of the drug utilization evaluation and drug
utilization review program. Improve patient care and reduce overall drug costs.
Analyze retrospectively the use of drugs by patients, physician
prescribing, and pharmacy dispensing activities. Identify and review critical patient profiles.
Report activities and important findings to medical consultants and
Interpret the therapeutic index values of different drugs used in
clinical medicine. Explain the difference between bioavailability and bioequivalence.
Explain the difference between one-compartment and multi-
compartment model. Explain the difference between high and low therapeutic index
Describedifferent selected therapeutic ranges of drugs.
! Discuss drug management and be able to:
• Clarify the difference between different type of drug management
• Describe the drug management of different type of diseases
• Describe the role of Pharmacist in prevention, patient counseling and
education of drugs according to national guidelines. • Explain
pharmacodynamics pharmacokinetic and drug management ! Discuss clinical pharmacokinetics and be able to:
• Interpret
pharmacokinetics on the basis of known variables, such as dose and time. • Explain different paradigms of Practical Pharmacokinetics such as,
ADME, clearance, volume of distribution, half-life, bioavailability, hepatic and renal elimination, linear pharmacokinetics, transport proteins, steady state serum concentration and pharmacodynamics of drugs. • Discuss patient specific-drug dosing, laboratory serum/plasma drug
samples and desirable pharmacologic effects without unwanted side effects of drugs. ! Discuss Pharmacoeconomics studies and be able to:
• Discuss role of Pharmacoeconomics in the pharmaceutical sector.
• Describe direct medical, direct non medical, indirect non medical,
intangible and incremental costs. • Describe cost-minimization, cost-benefit, cost-effectiveness and cost-
utility analysis in comparing treatment options. • Explain different Pharmacoeconomic methods such as, effective
formulary management, individual patient treatment, medication policy determination and resources allocation. SEMESTER – IX
COURSE NO. PHARM 721
COURSE TITLE: PHARMACY PRACTICE – VI A (ADVANCED CLINICAL
PHARMACY – II)
TRAINING OBJECTIVES OF CLERKSHIP PROGRAM
Fifteen weeks clerkship in Clinical pharmacy is a requirement of this training and students should be able to: • Apply their knowledge of pharmaceutics in clinical pharmacy setting.
• Observe and practice professional skil s required for a clinical pharmacist.
• Describe the etiology of a disease.
• Describe clinical features of a disease.
• Discuss different techniques used in interpreting clinical laboratory tests.
• Describe differential diagnostic tests, such as liver function tests, cardiac
• Discuss the basis of pharmacological and toxicological basis of diseases.
• Find out clinical literature from different sources such as, journals, internet
• Different drug-drug interactions, such as between warfarin and
• Describe different drug-food interactions, such as use of grape fruit juice,
supplements and oranges etc. • Describe the use of different antidotes used in emergency clinical
situations, such as naloxone, n-acetylcysteine. • Have knowledge of drugs used in pregnancy, such as folic acid for the
of neural tube defect in the newborn. • Understand mechanism of action and adverse effects of different drugs
cancer chemotherapy. • Discuss various genetic diseases, such as sickle cel anemia, diabetes
• Discuss knowledge of newer medicinal agents, such as interferon's,
SEMESTER – X
COURSE NO. PHARM 716
COURSE TITLE: PHARMACY PRACTICE – VI B (ADVANCED CLINICAL
PHARMACY – II) [THEORY]
At the end of the course, the students should be able to:
! Discuss pharmaceutical care, its scope, management and application of
care plan and

be able to:
Discuss role of a clinical pharmacist in the field of pharmacy practice.
Describe the management and application of pharmaceutical care
in pharmacy practice.
Explain in detail the establishment and organizing of the patient
record.
Describe the systematic approaches to patient therapy assessment
such as:
- subjective and objective data - diagnostic and pharmaceutical care plan - pharmacist's workup of drug therapy - inpatient pharmacy setting - number of medications prescribed or number of doses per day - drugs with a high risk of adverse drug effects or drug reactions - target diseases and high drug costs - Assessment of therapeutic goals & clinical therapy plan. ! Discuss disease management:
Understanding different type of disease management.
Identifying patient-specific drug-related problem.
Gather most valuable information from the patient's interview.
Clarify the patient's particular disease symptom or problem.
Devise a pharmacotherapy plan to rectify patient's problems.
Establish a clinical therapy plan for continuous or ongoing
Future patient counseling paradigms should be developed, i.e.
patient education. ! Discuss clinical therapeutics and be able to:
Discuss clinical therapeutics and describe the general management
of various disease states.
Interpret the clinical data as presented in literature and
extrapolatethe data on the basis of known variables, such as high or
low blood pressure etc.
Describe basic terminologies in disease prevention, management and
treatment.
Explain in detail different methods in drug selection for various
debilitating diseases, such as breast cancer, lung cancer, prostrate
cancer, AIDS etc.
• Discuss etiology, pathophysiology, clinical features and treatment of
various disease causes and be able to identify:
Diphenhydramine, Pseudoephedrine Ketorolac Opthalmic Drops Bisacodyl, mineral oil, enemas Allergic Rhinitis Loratadine, Cromolyn Sodium Loperamide, Azithromycin Isoniazid, ethambutol, pyrazinamide, gatifloxacin. Streptomycin, trimethoprim-sulfamethoxazole, ceftriaxone and ciprofloxacin. IGIM Vaccine, prophylaxis and therapy. Rabies immune globulin (RIG), prophylaxis. Lopinavir, Zidovudine Congestive Heart Failure Furosemide, Enalapril Iron supplements Omeprazole, ranitidine Diabetes Mel itis Metformin, Glipizide Hydrochlorothiazide, Atenolol Ribavarin, panadol Fluconazole, itraconazole ! Discus clinical toxicology and be able to:
• Explainclinical toxicology on the basis of clinical presentation of a
• Describegeneral role of pharmacist in management and treatment of
poisoning andoverdosage. • Describethe role and status of printed publications and poison control
POISINDEX (a computerized CD-ROM database). environmental series). - goldfrank'stoxicologic emergencies. poisoning and drug overdose. ! Discuss role of antidotes in modern medicine and be able to:
• Discussthe role of antidotes used in clinical practice.
• Extrapolate the toxicological data on the basis of known variables,
such as altered liver function tests. • Describe the adult and pediatric doses of different antidotes used in
Pharmacy practice. Describe historical perspectives and usage of antidotes in modern
! Discuss intravenous therapy and be able to:
Discuss rationale and safe use of intravenous therapy.
Describe various methods of support, such as total parenteral nutrition
and hyperalimentation, non protein sources, such as dextrose
monohydrate, IV lipids and protein (nitrogen) source, such as synthetic
crystal ine amino acids.
Discuss variousintravenous administration methods, such as central
venous catheter and peripheral venous catheter.
Discuss different systems used in parenteral nutrition, such as glucose
system parenteral nutrition and lipid system parenteral nutrition.
Describe various standard and modular formulas used in enteral
nutrition.
! Discuss compliance and non-compliance and be able to:
• Describe the difference between compliance and non-compliance.
• Explain in detail the methods, extent and reasons of non-compliance
in modern medicine. • Describe the strategies for improving compliance.
• Explain in detail the designing of compliance and non-compliance
SEMESTER – X
COURSE NO. PHARM 724
COURSE TITLE: PHARMACY PRACTICE – VI B (ADVANCED CLINICAL
PHARMACY – II)
TRAINING OBJECTIVES OF CLERKSHIP PROGRAM
Fifteen weeks clerkship in Clinical pharmacy is a requirement of this course and the students should be able to. Describe the etiology of microbial disease.
Determine the inpatient or outpatient setting in the hospital.
Describe empiric therapy and use of broad spectrum and multiple
antibiotic therapy.
Discuss monitoring of antibiotic therapy by assessing patterns, such as
fever curve, white blood cel count, radiographic findings, erythrocyte
sedimentation rate and serum complement concentration.
Describe general role of pharmacist in management and of a
poisoned patient, such as obtaining a history of exposure, skin
decontamination, gastric decontamination, emesis, gastric lavage,
whole-bowel irrigation, dialysis and hemoperfusion etc.
Describe the role and status of printed publications and poison control
centers.
Describe the role of antidotes in clinical toxicology such as, n-acetyl
cysteine, Fab antibody digoxin, naloxone etc.
Discuss numerous problems in hospitalized patients.
Describe the use of various vitamins, such as vitamin A, vitamin D,
vitamin E, vitamin K,thiamine, riboflavin, niacin, pantothenic acid,
biotin, folic acid and cyanocobalamin in malnourished patients.
Describe the use of various trace minerals, such as iron, zinc, copper,
manganese, selenium, iodine, chromium and molybdenum in
malnourished patients.
Describe the use of essential fatty acids, protein (nitrogen)
requirements, various electrolytes, growth factors, various standard
and modular formulas for EN formulations in hospitalized patients.
Discuss the use of essential nutrients, such as glutamine, arginine,
tyrosine, cytosine, newer cholesterol reducing agents, such as omega-
3 polyunsaturated fatty acids.
Discuss the use of newer antioxidants, such as oxepa to treat adult
respiratory distress syndrome.
SEMESTER – IX
COURSE NO. PHARM 712
COURSE TITLE: PHARMACY PRACTICE – VII A (FORENSIC PHARMACY)
[THEORY]
At the end of the course, the students should be able to:
! Define Drug Law and be able to
Describe history of drug legislation and pharmacy profession in
Discuss national health policy and national drug policy
Describe essential drugs
Define prescription handling at retail and recordkeeping
Discuss drug control administration at federal and provincial level
! Discuss role of forensic pharmacist
Describe forensic drug measurement
Discuss post-mortem redistribution (PMR)
Describe medication errors
Define prescription forgery
Discuss product tampering
Discuss insurance fraud
Discuss use of drugs or alcohol in car accidents or violent action
Describe legal and illegal pharmaceutical evidence in criminal
Discuss use of abused drugs in work place
Describe professional malpractice
Define quackery and health care fraud
! Describe pharmaceutical ethics
Describe patents and generics
Discuss ethics in sale
Describe ethics in industry
Define ethics in research
! Define Drug Law and be able to
Describe drug law
Discuss various aspects of drug law in detail
Describe application of drug law
Define drug act 1976 and other definitions
Discuss administration and enforcement of drug act 1976.
Discuss prohibitions
Discuss offences, penalties and procedures
! Define Provincial drug Rules and be able to:
Discuss direction to provincial Government and Provincial QC board
Describe provincial drug testing laboratory and discuss the Sindh
Discuss power of provincial Government to make rule
Discuss procedure and rules for sale of drug under heading of:
- Licensing authority - Duration of license - Cancel ation of license / suspension of license - Types of license - Conditions of license ! Define Drug Licensing, Registering& Advertising Rules and be able to:
Describe Registration of Drugs.
Describe Licensing of Drugs.
Describe Advertising Rules.
Describe drug labeling & Packing Rules.
! Define drug appel ate board rules.
Describe drug appel ate board
Describe Procedures of appeal
! Define drug import and export rules:
Discuss condition of license to import and export of drugs.
Discuss prohibition for import and export of drugs.
SEMESTER – X
COURSE NO. PHARM 717
COURSE TITLE: PHARMACY PRACTICE – VII B (FORENSIC PHARMACY)
[THEORY]
At the end of the course, the students should be able to:
! Describe pharmacy act 1967 and be able to:
Discuss and establishment of pharmacy council's composition of
provincial councils Discuss committees of central and professional councils
Describe qualification and registration procedure
! Describe dangerous drug act 1930 and be able to:
Discuss various aspects of dangerous drug act 1930
! Describe factory law 1934 and be able to:
Discuss protocols and legal aspects of factory law 1934.
! Discuss shops and establishment ordinance 1969 with rules and be able to:
Discuss protocols and rules of shop and establishment ordinance
! Describe poisons act 1919 and be able to:
Discuss power of provincial Government to regulate possession for
sale of any poison. Discuss power to regulate possession of any poison in certain areas
Explain presumption as to specified poison
Describe penalty for unlawful importation etc
Discuss rules regarding this act
! Describe control of narcotics substance act 1997 and be able be:
Discuss classification and scheduling of drugs of abuse and
controlled chemicals Discuss registration and licensing procedure
Discuss procedures of inspection for compliance.
SEMESTER – IX
COURSE NO: PHARM 713
COURSE TITLE: PHARMACY PRACTICE – VIII A (PHARMACEUTICAL
MANAGEMENT & MARKETING) [THEORY]
At the end of the course, the students should be able to:
! Define management and be able to:
Describe the nature of management.
Describe the principles of management.
Discuss the managerial job types.
Describe the four different functions of management.
Describe planning in detail.
Discuss the purpose and types of planning.
Describe the different steps in planning.
Describe organizing in detail.
Discuss the management control systems.
Describe purpose of the control system
Describe the steps in the control process.
Discuss forms of operation control.
Describe requirement for adequate control and critical control points
Describe motivation in detail.
Describe innovation and creativity.
! Describe production management and be able to:
Discuss material management, planning of production, batch
record maintenance. SEMESTER – X
COURSE NO. PHARM 718
COURSE TITLE: PHARMACY PRACTICE – VIII B (PHARMACEUTICAL
MANAGEMENT & MARKETING) [THEORY]
At the end of the course, the students should be able to: ! Define marketing management and be able to:
• Describe principles of marketing
• Describe
• Discuss
Differences between pharmaceutical marketing and consumer marketing • Discuss Ethical consideration of pharmaceutical marketing
• Discuss marketing research
• Discuss promotion.
• Discuss product management
• Discuss Market analysis technique 3Cs (customer analysis, company
analysis, and competitors' analysis. • Discuss Evaluating the market performance(audit tools and audit
• Describe marketing channels, promotion and advertising and
! Sales Management:
• Discuss Personnel, buying, receiving, pricing, sales promotion and
customer services. • Designing sales force structure, sales force size and sales quota.
! Business Development Management
• Discuss General principles, strategies, short and long term planning
! Business Communication
• Describe Importance and benefits of business communication,
components of communication, concept and problems of communication,7C' of communication. ! Strategies for Successful Business and Global Meeting
• Discuss Background information on groups, purpose and kinds of
meetings, solving problems in meetings, leadership responsibilities in meetings, participant' responsibilities in meetings. (7) BOOKS FOR PHARM.D. FIFTH PROFESSIONAL
AVAILABLE IN LEARNING RESOURCE CENTER (LRC)
COURSE NO. PHARM 714, 719, 722 & 725
PHARMACEUITCAL CHEMISTRY – IV A & IV B (MEDICINAL CHEMISTRY)
! Foye Wil iam O. Principles of Medicinal Chemistry, Lippincott, Wil iams and Wilkins, sixth edition, 2008. ! Wilson and Gisvold's text book of organic and pharmaceutical Chemistry, Lippincott, Wil iams and Wilkins, Eleventh edition, 2004. ! An Introduction to the medicinal chemistry Graham L. Patrick, Oxford University Press, fourth edition,2009. ! Tyagi. Text Book of Synthetic Drugs, Anmol Publications, Dehli, 2004. ! Block, Roche, Soine and Wilson. Inorganic and Medicinal Pharmaceutical Chemistry, Verghese Publishing House, Bombay, 1986. ! Alferd Burger. Medicinal Chemistry, Jhon Wil ey & Sons, New York, 2003. ! Block, Roche, Soine and Wilson. Inorganic and Medicinal Pharmaceutical Chemistry. Lee second edition . Verghese Publishing House 1986. COURSE NO. PHARM 710, 715, 720 & 723
PHARMACEUTICS – VII A & VII B (PHARMACEUTICAL TECHNOLOGY)
! Anya M. Hel ery. Drug Delivery and Targeting, Taylor & Francis, London, ! Joseph R. Robinson. Control ed Drug Delivery, Marcel & Dekker Inc, NewYork, 2nd Ed., 1987. ! T.V.Ramabhadran. Pharmaceutical Design and Development, El is Horwood, NewYork, 1994. ! M.E. Aulton. Pharmaceutics: Science Of Dosage Forms Design, ELBS/ Churchil Living stone, London, 1998. ! Banker. Modern Pharmaceutics, Marchel Dakker Inc, New York, 1990. ! John A. Bontempo. Development of biopharmaceutical parenteral dosage forms, Marchel Dakker Inc, New York, 1997. ! N.K. Jain. Control ed and Novel Drug Delivery, CBS Publishers & Distributors, New Delhi, 1997. ! Ansel. Pharmaceutical Dosage Form in Drug Delivery System, Lee and Febiger, London, 1990. ! Attaurahman and M.I. Chaudary. Bioassay techniques for drug development, CRC Press LLC USA, 2001. ! Pramod K. Gupta. Injectable drug development, CRC Press LLC USA, 1999. ! H.John Smith, Introduction to the principles of drug design and action CRC Press LLC USA, 1998. ! Rong Liu. Water Insoluble Drug Formulations, CRC Press LLC USA, 2000. ! Peter Blaisdel , Twenty First Century Pharmaceutical Development, CRC Press LLC USA, 2000. ! Lachman L. Theory and Practice of Industrial pharmacy, Lee and Febiger Phildelphia, 3rd Ed., 1986. COURSE NO. PHARM 711, 716, 721 & 724
PHARMACY PRACTICE – VI A & VI B (ADVANCED CLINICAL
PHARMACY – II)
! Roger Walker. Clinical Pharmacy & Therapeutics, Churchil Levingstone, London, 3rd Ed., 2003. ! Guard Paul. A Behavioral Approach to Pharmacy Practice, Black Wel , ! HerfindalGourley. Clinical Pharmacy & Therapeutics, Wil iam &Wil kins, ! A.J. Winfield. Pharmaceutical Practice, Churchil Levingstone, London, 2nd ! Kevin Taylor. Pharmacy Practice, Taylor & Francis, New York, 1998. ! Deborah Rosenbaun. Clinical Research Coordinator Hand Book, 2nd edition, Sarrison, Inc North Carolina, USA. ! Joseph T. Dipiro. Encyclopedia of Clinical Pharmacy, Marcel Dekker Publishing, 2003. ! Joseph T. Dipiro. Encyclopedia of Pharmacy, Marcel Dekker Publishing, ! Mel ainie J. Rantucci. Pharmacist Talking with Patients. 1997. ! Smith GDG and Aronson JK. Oxford Text Book of Clinical Pharmacology and Drug therapy, Oxford Uni. Press, UK. 1990. ! Hansten P and Horn J. Drug interactions. Lee and Febiger, Philadelphia, COURSE NO. PHARM 712 & 717
PHARMACY PRACTICE – VII A & VII B (FORENSIC PHARMACY)
! R.Z. Hussain. The Manual of Drug Laws in Pakistan, Irfan Law Book House, Lahore Pakistan, 2003. ! The Pharmacy Act 1967. ! Kokate CK, Gokhale SB. Text book of forensic pharmacy. 5th edition, Edward Arnold; 1959. ! The Poison Act 1919. ! The Dangerous Drugs Act 1930. ! The Factory Law 1934. ! Shop and Establishment Ordinance 1969. ! Control of Narcotics Substances Act 1997. COURSE NO. PHARM 713 & 718
PHARMACY PRACTICE – VIII A & VIII B (PHARMACEUTICAL
MANAGEMENT & MARKETING)
! M. Ahmed & N.I. Bukhari. Pharmaceutical Management and Marketing, Tariq Academy, Faisalabad, Pakistan. 2002. ! C. Patrick Tharp & Pedro J. Lecca. Pharmacy Management for students and practitioners, The C.V. Mosby Company, St. Louis, Toronto, London. ! Harry A. Smith. Principles & Methods of Pharmacy Management, Lee and Febiger Philadelphia. 1986. ! Herta MA,Herbert HW ,Jeans TP Effective Business communication 8th ! Lidstone J,Maclennan J. Marketing Planning for the pharmaceutical industry 2nd Ed.Gower Pubco;1999 (8) EXAMINATION RULES AND REGULATION, FOP
PHARM.D 1ST TO 5TH PROFESSIONAL

The system of examination in the Faculty of Pharmacy of Ziauddin University shal
be based on semester system. The detailed rules and regulations are as follows.

8.1 Academic Calendar
A calendar of academic and co-curricular activities during an academic year shal be cal ed ACADEMIC CALENDAR.
▪
An academic year shal be divided into two Semesters, each
of 16 to 17 weeks duration. 8.2 Courses
Each course (Theory or practical) wil have a number, a short title and
number of credit hours (cr. hrs). A number once denoted, shal not be
changed even if course is withdrawn or abolished.

8.3 Types of Examinations
Continuous Assessment Tests
Are conducted by Faculty of Pharmacy. Are conducted for regular candidates and for the candidates repeating the year. Candidates repeating the year have to score fresh Continuous Assessment marks for the failed course(s). Previous Continuous Assessment marks shal be cancel ed. (See point No. 9) Different methods of evaluation wil be used to judge student's performance. These include tests / assignments / presentations / viva. Weightage
1st to 10th
Semester
40%
For example, in a course if a student obtains 40 marks out of 100, this means he/she has obtained 16 marks (a) out of 40 in that particular course which wil be added to Regular Semester Examination marks (b) obtained in that course for complete Regular Semester Examination
Is conducted by the Ziauddin University Department of The examination schedule is prerogative of the University; no changes would be made once the schedule is announced. Any query related to examination should be addressed to the Dean, Faculty of Pharmacy. is held at the end of 1st and 2nd semester of each academic Weightage
1st to 10th
Semester
60%
For example, in a course if a student obtains 60 marks out of 100, this means he/she has obtained 36 marks (b) out of 60 in that particular course which wil be add up to Continuous Assessment marks (a) for complete score, i.e. (a + b ) 16+36= 52 out of 100 Semester Resit Examination
Is conducted by the Ziauddin University Department of Resit Examination of both the semesters wil be held at the end of the academic year (after declaration of 2nd semester result) 8.4 Marking System/Pass level
Each course of a semester carries 100 marks. The minimum passing marks of each course are 50% and are sum of Continuous Assessment marks and Regular Semester Examination marks. " 40% weightage of Continuous Assessment of any course shal
not be counted towards Resit Examination and students must
obtain a minimum 50% marks to clear the course. " 40% weightage of the current Continuous Assessment of any
course shal be added in the Regular Semester Examination
marks for the candidate repeating the year.
8.5 Grading System
Grades awarded to a student in each course shall be of two types: Numerical Grade (NG): Assessment of performance on the basis of
marks out of 100 fixed for a course unit is NG. Alphabetical Grade (AG) Equivalent of numerical grade in Semesters
of alphabets shal be denoted by AG. (Each letter carries a definite value in semesters of numerical points or grades points). There shall be 12 AGs, which are given below: Grade Point
• Grade Point Ratio (GPR): Points obtained in each course shal be
multiplied by the number of credit hours specified for that course and dividing the total by the total number of credit hours. • Cumulative Grade Point Ratio (CGPR): This is obtained by adding al
the grade points of the courses during five years of study period and dividing the total by the total number of credit hours. 8.6 Eligibility for Regular Semester Examination
Minimum 80% attendance in each course is mandatory. Attendance requirement is applicable to al scheduled activities of learning namely lectures, tutorials, presentations, assignments, written
examinations, viva, visits to pharmaceutical industries, clerkships and
other related activities. Clearance of al University dues. Students who do not meet the attendance requirement for one or more than one course(s) wil be detained from appearing in the semester examination(s) of that course(s). He/She wil be considered as Not Eligible student. 8.7 Eligibility for Resit Examination
Failure of the Regular Semester Examination. Student who remains absent in the Semester Examination. Student who has at least 65% attendance in the course(s) wil be
eligible to appear in the Resit Examination only after submitting assignments (2 assignments per 5% shortage of attendance for each course) which wil be thoroughly evaluated and marked by the course Incharge(s). Students having less than 65% attendance in any course will not be eligible to appear in Resit Examination, and wil have to repeat the • Promotion rules
Promotion wil be declared yearly i.e. after each 2nd semester Promotion to next class wil be based on passing 100% courses
of the current academic year (Two semesters) 8.8 Rules for Repeating the year
A student who fails to clear 100% courses of the year after Resit Examination of that year wil be considered as a Repeater.
A student repeating the year wil attend al the classes of the course(s) Theory/Practical in which he/she was declared failed. However his/her eligibility wil not be affected with his/her Student, repeating the year wil appear in al Continuous Assessment tests/viva of the respective course(s) in which he/she was declared failed. He/She can avail 2 chances (regular + Resit) each year. 8.9 Declaration of Result
• Result of Continuous Assessment (test/assignment/presentation/ viva) of each course, signed by the course Incharge and the Dean, wil be displayed on the notice board of the Faculty of Pharmacy. Result of Semester examination conducted by the University shal be announced by the Control er of Examinations. 8.10 Issuance of Marks sheet
The Department of Examination wil issue mark sheet of Semester 8.11 Requirement for the award of Pharm. D Degree
A student must have passed al the prescribed courses, of 1st to 5th A student must have obtained a minimum CGPR of 2.45. A student who fails to achieve CGPR 2.45: He / She shall be allowed to sit in the regular Semester Examination of the year to improve his / her CGPR. He / She allowed to improve his / her CGPR by attempting the course(s) in which he / she have secured C or D grade only in the regular and resit examination of 1st to 4th year. 5th year students may appear in the Resit Examination of 5th year both semesters. ▪ The best grade out of al attempts in that course(s) shal be
include in the calculation of CGPR. Weightage of continuous assessment shal not be included in the grade improving examination ▪ There is no restriction on the number of attempts for the
improvement of grades. Unfair means
All cases of using unfair means and practice during examination wil be forwarded to the Disciplinary Committee of the University appointed for the purpose. The matter wil be dealt with in accordance with the rules and regulations of the University. In case of any dispute in interpretation of the rules, the Vice Chancel or wil be the final deciding authority. • External examiner
There shal be external examiners in al practical courses. 8.12 Declaration by student / parent wil be taken before examination
I hereby declare that I have read rules and regulations regarding
examination policy 2013 – 2014 and wil duly abide by the prescribed rules and
(9) TEST ADMINISTRATION RULES & REGULATIONS, FOP
9.1 GENERAL
! All university examinations are monitored by the Department of Examination with the support of the Dean, Faculty and staff. ! To ensure that the examinations are held according to the standard conditions and that no examinee or group of examinees receives unfair advantage on the examination, students (examinees) must
strictly adhere/abide to the rules and regulations of the Faculty of
Pharmacy, Ziauddin University.
9.2 IRREGULAR BEHAVIOUR/ PRACTICES
Specific examples of irregular behavior include, but are not necessarily
limited to the following:
• Copying answers from another examinee or al owing answer • Making notes of any kind during an examination. • Failure to fol ow instructions of the staff present in the examination hal . • Acts of disruptive behavior such as raising ones voice, talking to others, interrupting the examination process upon entering the examination hal , or during an examination, and other similar acts • During an examination usage of any unauthorized material such as photographic equipment, communication or recording devices, including electronic paging devices and cel ular • Altering or misrepresenting examination result, theft or unauthorized possession of examination materials. • Memorizing and reproducing examination materials and any unauthorized reproduction by any means and / or dissemination of examination material. • Looking in the direction of another examinees, passing of written notes, leaving written notes on vacant seats/ desks not occupied by examinees during the examination may be considered as evidence of copying or attempting to copy, and a report of such behavior may result in irregular behavior/practice. • Sitting for an examination without being eligible for it, impersonating an examinee or engaging a proxy to take the 9.3 Advice for Students:
What to do
• Students should arrive at the examination hall before scheduled
time. Incase if any student arrives late that is after scheduled time, he / she is not to be admitted. Students arriving within 10 minutes after scheduled testing time may be admitted by the approval of head examiner or official of the Department or Examination. • Students should present Col ege Identity Card, Admit Card and
wear Lab. Coat for Continuous Assessment Terminal / Resit Examinations. If any student/s does not bring the required Identification Card & Lab coat, he / she may not be admitted to the examination hal . What NOT to do
• Do not bring into the examination hall any personal belongings,
including mechanical or electrical devices, backpacks, handbags, books, notes or study guide materials, calculators, digital watches, watches with computer communication and / or memory capability, electronic paging devices, recording or filming devices, radios, cel ular telephones, food and drinks. Only for specified subject/s (like mathematics, statistics, physical pharmacy, biopharmaceutics and pharmacokinetics etc) special instruction wil be given on use of scientific calculator for examination. • Dot not make written notes or record in any way the contents of
any examination. Any notes found wil be confiscated and reported for disciplinary action. • Do not communicate with, seek aid from, or provide aid to any
other examinee during the examination. • Once you (students) start taking an examination, you cannot
cancel that examination. • If the test is completed less than the time allotted then do not leave
without seeking permission from the staff present in the examination No extra time wil be al owed if he/she leaves the examination hal for personal emergency. Between exam duration, examination clock continues to run. 9.4 Evaluation of students:
• In the middle of the each semester a complete profile of continuous Assessment (Test marks, Viva marks and attendance) of each course regularly delivered to their parents. • In case of unsatisfactory results in more than 3 courses, the student's parents are asked to visit to the Dean's office. • A Parents / Teacher meeting is regularly cal ed after the result of 1st term examination of each year. • Continuous counseling and evaluation regarding the Examination / Attendance rules and regulation of Ziauddin Faculty of Pharmacy, is carried out during each semester. Anyone having information or evidence indicating that
any type of irregular behavior has occurred should
immediately report to the Dean, Faculty of Pharmacy
and / or Controller of Examinations
! Students (examinees) observed in act/s that is/are possible violation
of test administration rules or other forms of irregular behavior during
an examination wil be reported by staff present at the time of the
examination for disciplinary

! Failure to adhere or abide the given rules and regulation wil be
considered as irregular behavior, and student/s found in the act
may lead to expulsion from the Faculty of Pharmacy, ZU

Source: http://www.zu.edu.pk/images/pdf/guidebooks/pharmacy/guidebook_%20semester9_10.pdf